Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted) (2021 - 2026)

Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Cullinan Therapeutics 368.65 Mn 368.65 Mn - 58.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.34 Mn
Dec 31, 2025 58.34 Mn
Sep 30, 2025 58.34 Mn
Jun 30, 2025 58.34 Mn
Mar 31, 2025 58.34 Mn
Dec 31, 2024 58.34 Mn
Sep 30, 2024 58.34 Mn
Jun 30, 2024 55.05 Mn
Mar 31, 2024 43.01 Mn
Dec 31, 2023 41.55 Mn
Sep 30, 2023 42.73 Mn
Jun 30, 2023 39.95 Mn
Mar 31, 2023 40.68 Mn
Dec 31, 2022 46.64 Mn
Sep 30, 2022 45.61 Mn
Jun 30, 2022 46.38 Mn
Mar 31, 2022 44.43 Mn
Dec 31, 2021 43.08 Mn
Sep 30, 2021 43.44 Mn
Jun 30, 2021 43.30 Mn